veratridine has been researched along with guanfacine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Näsström, J; Post, C; Uhlén, S; Wikberg, JE | 1 |
| Chen, W; Marvizón, JC; Song, B | 1 |
2 other study(ies) available for veratridine and guanfacine
| Article | Year |
|---|---|
Guanfacine inhibits excitatory amino acid release from rat cerebral cortex through a non-adrenergic mechanism.
Topics: Amino Acids; Animals; Aspartic Acid; Autonomic Nervous System; Cerebral Cortex; Dioxanes; Glutamates; Guanfacine; Guanidines; Idazoxan; In Vitro Techniques; Male; Phenylacetates; Prazosin; Rats; Rats, Inbred Strains; Veratridine | 1989 |
Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics, Opioid; Animals; Brimonidine Tartrate; Clonidine; Data Interpretation, Statistical; Electric Stimulation; Enkephalins; Guanfacine; Immunohistochemistry; Male; Medetomidine; Microscopy, Confocal; Oligopeptides; Protease Inhibitors; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, mu; Spinal Cord; Veratridine | 2008 |